SODIUM CHLORIDE 0.9% w/v And DEXTROSE 5% w/v Intravenous Infusion B.P. Price

Overview

Welcome to Dwaey, specifically on SODIUM CHLORIDE 0.9% w/v And DEXTROSE 5% w/v Intravenous Infusion B.P. Infusion/Solution for page.
This medicine contains an important and useful components, as it consists of Dextrose (anhydrous), Sodium chloride.
SODIUM CHLORIDE 0.9% w/v And DEXTROSE 5% w/v Intravenous Infusion B.P. is available in the market in concentration 50mg, 9mg/ml and in the form of Infusion/Solution for.

KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES CO. (KSPICO) is the producer of SODIUM CHLORIDE 0.9% w/v And DEXTROSE 5% w/v Intravenous Infusion B.P. and it is imported from KUWAIT, The most popular alternatives of SODIUM CHLORIDE 0.9% w/v And DEXTROSE 5% w/v Intravenous Infusion B.P. are listed downward .

Mode Of Action

Dextrose and sodium chloride solutions are used as sources of electrolytes, calories and water for hydration. Sodium and chloride ions are responsible for regulating the acid-base balance of the body. Dextrose is a source of calories. It is readily metabolised and helps to decrease losses of body protein and nitrogen. It also promotes glycogen deposition and decreases or prevents ketosis.

Indication

• Dehydration
• Fluid and Electrolytes imbalance

Precaution

May cause fluid and/or solute overload. Caution when used in patients with CHF, severe renal impairment or clinical conditions whereby there is sodium retention with oedema. Monitor serum potassium levels. Not to be administered concurrently with blood through the same infusion set due to risk of agglomeration. Patients with overt or known subclinical DM, or carbohydrate intolerance. Risk of hypokalaemia during parenteral admin of hypertonic dextrose solutions. Paediatric patients especially neonates and very low birth weight infants. Caution when used in patients receiving corticosteroids or corticotropin. Pregnancy.

Side Effects

• Fever
• infection at the site of inj
• venous thrombosis or phlebitis extending from the site of inj
• extravasation and hypervolaemia.

Contra indication

Allergy to corn products.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks